Michael Nebozhyn
0000-0001-8835-7714
Publication & Citation Trends
Most Cited Works
Publications
162 total
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Cited by 2,287
OpenAlex
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma PDF
Cited by 131
OpenAlex
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02 PDF
Cited by 131
OpenAlex
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC PDF
Cited by 213
OpenAlex
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Cited by 2,211
OpenAlex
Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature.
Cited by 199
OpenAlex
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing PDF
Cited by 197
OpenAlex
Research Topics
Cancer Immunotherapy and Biomarkers
(53)
Colorectal Cancer Treatments and Studies
(47)
Cancer Genomics and Diagnostics
(24)
Pancreatic and Hepatic Oncology Research
(23)
RNA modifications and cancer
(22)
Frequent Co-Authors
Affiliations
The Wistar Institute
Boston University
Ulsan College
Universitat Autònoma de Barcelona
Oslo University Hospital